Determination of ivermectin in plasma and whole blood using LC-MS/MS
Journal article
Kaewkhao N. et al, (2024), Wellcome Open Research, 9, 231 - 231
A pharmacokinetic randomised interventional study to optimise dihydroartemisinin-piperaquine dosing for malaria preventive treatment in Malawian infants: A protocol for the OPTIMAL study
Journal article
Banda CG. et al, (2024), Wellcome Open Research, 9, 291 - 291
Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants
Journal article
Wattanakul T. et al, (2024), Nature Communications, 15
Comparison of lumefantrine, mefloquine, and piperaquine concentrations between capillary plasma and venous plasma samples in pregnant women with uncomplicated falciparum and vivax malaria
Journal article
Saito M. et al, (2024), Antimicrobial Agents and Chemotherapy, 68
Safety, pharmacokinetics, and potential neurological interactions of ivermectin, tafenoquine, and chloroquine in Rhesus macaques.
Journal article
Vanachayangkul P. et al, (2024), Antimicrobial agents and chemotherapy
Determination of ivermectin in plasma and whole blood using LC-MS/MS
Journal article
Kaewkhao N. et al, (2024), Wellcome Open Research, 9, 231 - 231
Medication adherence framework: A population‐based pharmacokinetic approach and its application in antimalarial treatment assessments
Journal article
Ding J. et al, (2024), CPT: Pharmacometrics & Systems Pharmacology
Pharmacokinetics of single low dose primaquine in Ugandan and Congolese children with falciparum malaria
Journal article
Mukaka M. et al, (2023), eBioMedicine, 96, 104805 - 104805
The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance.
Journal article
Cavany S. et al, (2023), Nature communications, 14
Evidence based optimal dosing of intravenous artesunate in children with severe falciparum malaria
Journal article
Haghiri A. et al, (2023), Clinical Pharmacology & Therapeutics
Clinical needs assessment to inform development of a new assay to detect antimalarial drugs in patient samples: A case study
Journal article
Coonahan ES. et al, (2023), PLOS Global Public Health, 3, e0002087 - e0002087
Safety and efficacy of artesunate treatment in severely injured patients with traumatic hemorrhage. The TOP-ART randomized clinical trial.
Journal article
Shepherd JM. et al, (2023), Intensive care medicine, 49, 922 - 933
Activity of Ivermectin and Its Metabolites against Asexual Blood Stage Plasmodium falciparum and Its Interactions with Antimalarial Drugs.
Journal article
Yipsirimetee A. et al, (2023), Antimicrobial agents and chemotherapy, 67
Ivermectin metabolites reduce Anopheles survival.
Journal article
Kobylinski KC. et al, (2023), Scientific reports, 13
Safe drugs with high potential to block malaria transmission revealed by a spleen-mimetic screening
Journal article
Carucci M. et al, (2023), Nature Communications, 14
Safety of age-dosed, single low-dose primaquine in children with glucose-6-phosphate dehydrogenase deficiency who are infected with Plasmodium falciparum in Uganda and the Democratic Republic of the Congo: a randomised, double-blind, placebo-controlled, non-inferiority trial
Journal article
Taylor WR. et al, (2023), The Lancet Infectious Diseases, 23, 471 - 483
Intravenous Doxycycline, Azithromycin, or Both for Severe Scrub Typhus
Journal article
Varghese GM. et al, (2023), New England Journal of Medicine, 388, 792 - 803
Mass Spectrometry-Based Metabolomics Revealed Effects of Metronidazole on Giardia duodenalis.
Journal article
Popruk S. et al, (2023), Pharmaceuticals (Basel, Switzerland), 16
Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV)
Journal article
Schilling WHK. et al, (2023), eLife, 12
Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria.
Journal article
Odera DO. et al, (2023), Science translational medicine, 15